Arkansas Legal Resource Navigator

17-104-102. Definitions.

Arkansas Code — all titles (historical 2020) · legal_authorities

17-104-102. Definitions.

17-104-102. Definitions. As used in this chapter: (1) “Extracorporeal circulation” means the diversion of a patient's blood through a heart-lung machine or a similar device that assumes the functions of the patient's heart, lungs, kidneys, liver, or other organs; (2) “Licensed perfusionist” means a person licensed under this chapter; (3) “Perfusion” means the functions necessary for the support, treatment, measurement, or supplementation of the cardiovascular, circulatory, or respiratory systems or other organs, or a combination of those activities, and to ensure the safe management of physiologic functions by monitoring and analyzing the parameters of the systems under an order and supervision of a licensed physician, including: (A) The use of extracorporeal circulation, long-term cardiopulmonary support techniques, including, but not limited to, extracorporeal carbon-dioxide removal and extracorporeal membrane oxygenation and associated therapeutic and diagnostic technologies; (B) Counterpulsation, ventricular assistance, autotransfusion, blood conservation techniques, myocardial and organ preservation, extracorporeal life support, and isolated limb perfusion; (C) The use of techniques involving blood management, advanced life support, and related functions; (D) The administration of pharmacological and therapeutic agents or blood products or anesthetic agents through the extracorporeal circuit or through an intravenous line for perfusion purposes as ordered by a physician; (E) The performance and use of: (i) Anticoagulation monitoring and analysis; (ii) Physiologic monitoring and analysis; (iii) Blood gas and chemistry monitoring and analysis; (iv) Hematologic monitoring and analysis; (v) Hypothermia; (vi) Hyperthermia; (vii) Hemoconcen

Source: Arkansas Code — historical release 78 (November 6, 2020) · 17-104-102

Stored review status: Historical 2020-11-06 source release; later amendments not reconciled; machine-extracted, not independently legally reviewed; source heading status: text_in_historical_source. A text match is a research starting point; applicability is not established.

Issuing source page ↗

Authority boundary: historical statutory source snapshot not current law.

Open the recorded source website ↗

Record provenance

Stable record: arkansas_code:legal_authorities:17-104-102
Source file: gov.ar.code.title.17.odt
Pages: Not recorded – Not recorded
Passage SHA-256: 8a4e01189ff88a6d64c49b381f74c891ad98da502594cbacd339d99dbc49c4b4

Source location: content.xml paragraph 32652

Stored source content

17-104-102. Definitions. As used in this chapter: (1) “Extracorporeal circulation” means the diversion of a patient's blood through a heart-lung machine or a similar device that assumes the functions of the patient's heart, lungs, kidneys, liver, or other organs; (2) “Licensed perfusionist” means a person licensed under this chapter; (3) “Perfusion” means the functions necessary for the support, treatment, measurement, or supplementation of the cardiovascular, circulatory, or respiratory systems or other organs, or a combination of those activities, and to ensure the safe management of physiologic functions by monitoring and analyzing the parameters of the systems under an order and supervision of a licensed physician, including: (A) The use of extracorporeal circulation, long-term cardiopulmonary support techniques, including, but not limited to, extracorporeal carbon-dioxide removal and extracorporeal membrane oxygenation and associated therapeutic and diagnostic technologies; (B) Counterpulsation, ventricular assistance, autotransfusion, blood conservation techniques, myocardial and organ preservation, extracorporeal life support, and isolated limb perfusion; (C) The use of techniques involving blood management, advanced life support, and related functions; (D) The administration of pharmacological and therapeutic agents or blood products or anesthetic agents through the extracorporeal circuit or through an intravenous line for perfusion purposes as ordered by a physician; (E) The performance and use of: (i) Anticoagulation monitoring and analysis; (ii) Physiologic monitoring and analysis; (iii) Blood gas and chemistry monitoring and analysis; (iv) Hematologic monitoring and analysis; (v) Hypothermia; (vi) Hyperthermia; (vii) Hemoconcentration and hemodilution; and (viii) Hemodialysis; and (F) The observation of signs and symptoms related to perfusion services, the determination of whether the signs and symptoms exhibit abnormal characteristics, and the implementation of appropriate reporting, perfusion protocols, or changes in or the initiation of emergency procedures; (4) “Perfusion protocols” means perfusion-related policies and protocols developed or approved by a licensed healthcare facility or a physician through collaboration with administrators, licensed perfusionists, and other healthcare professionals; and (5) “Provisional licensed perfusionist” means a person provisionally licensed under this chapter.

Cross-references

Connections may be documented source relationships, shared citations or nearby passages. Each explains its basis; a connection alone does not establish applicability to your situation.

No explicit source connection was found. This does not mean there are no relevant authorities.